• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Battery Ventures Acquires Analytical-Instrumentation Pioneer LI-COR Biosciences

Share:

December 13, 2021

Battery Ventures, a global, technology focused investment firm, has acquired LI-COR Biosciences, an industry-leading company that makes highly engineered instrumentation systems for environmental research, agriculture, drug discovery, protein research and therapeutics development.

LI-COR, founded by Bill and Elaine Biggs, has two main business lines: environmental-monitoring instrumentation, including devices and software for scientists to analyze plants, atmospheric qualities, gas and soil, and a biotechnology business, offering a portfolio of imaging and analysis instruments, proprietary software and reagents sold mainly to life-science research institutions and pharmaceutical producers.

An increased need for climate-change analysis and adaptation, as well continued global population growth and the need to improve food production, are larger trends pushing the adoption of LI-COR’s environmental products. LI-COR’s biotechnology products help researchers improve the human condition through innovative research tools that help scientists solve global health challenges. Based in Lincoln, Neb., the company counts more than 3,000 academic and commercial customers across 100 countries and operates two subsidiaries in Germany and the United Kingdom.

“We are excited to partner with LI-COR and the Biggs family in this transaction, particularly since we’ve been tracking the company and its growth since 2013,” said Jesse Feldman, a Battery Ventures general partner. “We look forward to helping LI-COR increase its market share and grow both organically and through targeted acquisitions.” Feldman and Battery’s Max-Julian Kaye are joining LI-COR’s board.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

As part of the acquisition, current LI-COR Chief Executive Greg Biggs, the son of co-founder Bill Biggs, will transition to an advisory role. Thomas Reslewic, a current Battery executive-in-residence who previously served as group president for two business units within Teledyne Technologies, will become CEO. At Teledyne, Reslewic managed a portfolio of companies producing a range of scientific instruments, environmental-monitoring equipment, and test-and-measurement solutions, among other products.

“LI-COR has incredibly strong heritage as an innovator in both of its core markets, which continue to present exciting opportunities for organic and inorganic growth,” Reslewic said. “I am excited to assume this new role and to lead LI-COR in its next chapter of growth as a category leader.”

Greg Biggs noted: “Partnering with Battery, a well-capitalized firm with an extensive history of backing innovative analytical-instrument businesses, is the logical evolution for LI-COR. We could not be more thrilled to leverage Battery’s capital, network and industry expertise to continue to drive our growth in this dynamic industry environment.”

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Joe Kvedar, MD, New President-Elect of the ATAJoe Kvedar, MD, New President-Elect of the ATA
  • Bringing the Internet of Things to healthcareBringing the Internet of Things to healthcare
  • Why Patient Trust is Key for Burgeoning Retail Healthcare ProvidersWhy Patient Trust is Key for Burgeoning Retail Healthcare Providers
  • 5 Disruptive Technologies Driving The Future of Patient Monitoring Solutions5 Disruptive Technologies Driving The Future of Patient Monitoring Solutions
  • Amyris to Acquire EcoFabulous Clean Beauty Brand Focused on Fast-Growing Gen Z Consumer SegmentAmyris to Acquire EcoFabulous Clean Beauty Brand Focused on Fast-Growing Gen Z Consumer Segment
  • CRH Medical Corporation Announces Completion of Majority Acquisition of Triad Sedation Associates, Llc
  • Boston Scientific Bets $1.75 Billion on Baylis Medical’s Heart PortfolioBoston Scientific Bets $1.75 Billion on Baylis Medical’s Heart Portfolio
  • Social Determinants Of Health Pose Challenges For Most Americans, Survey ShowsSocial Determinants Of Health Pose Challenges For Most Americans, Survey Shows

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications